Global Pharmaceutical Contract Manufacturing Service Procurement: 2018 Market Intelligence Report – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Pharmaceutical Contract Manufacturing Service – Procurement Market Intelligence Report” report has been added to ResearchAndMarkets.com’s offering.

The category spend momentum is attributed to the cost savings of about 28%-32% that contract manufacturing of drugs enables while enhancing the drug development process. CMOs provide access to novel technologies and innovative platforms that can enhance speed-to-market and help buyers to remain competitive.

This report provides actionable insights to improve source-to-contract cycle performance in the Global Pharmaceutical Contract Manufacturing Services Market. It helps sourcing professionals formulate better category strategies, enhance savings, understand supplier and market challenges, and implement sourcing best practices.

The report provides up-to-date information about market shifts and potential risks, as well as in-depth knowledge of products and services, which can help in planning and in executing category management activities. It focuses on the cost-saving aspects of procurement and on providing insights that can lead to optimization of category spend.

One of the procurement best practices for buyers in the global pharmaceutical contract manufacturing service market is to establish a supplier quality enhancement program.

According to the report, one of the key growth drivers for the global pharmaceutical contract manufacturing service market is the high demand for pharmaceutical contract manufacturing services from biopharmaceutical industry. The biopharmaceutical industry is increasingly outsourcing services to CMOs due to the need for additional capacity and access to capabilities and technologies that they lack.

Further, the report states that one of the key procurement challenges faced by buyers is the difficulty in demand forecasting for biologic drug production. The biologics drug development and approval process are long and fraught with complications, resulting in risk of inaccurately forecasting demand.

Category drivers

• Advances in medical science such as stem cell research and combination drug therapy
• For a full, detailed list, view the report…

Category management strategy

• Rationalization of the supply base
• For a full, detailed list, view the report…

Procurement best practices

• Establish quality enhancement programs for suppliers
• For a full, detailed list, view the report…

Key questions answered in this report

• What are the market dynamics?
• What are the key market trends?
• What are the category growth drivers?
• What are the constraints on category growth?
• Who are the suppliers in this market?
• What are the demand-supply shifts?
• What are the major category requirements?
• What are the procurement best practices in this market?

Key Topics Covered

PART 01: Executive Summary

Global category spend

Category spend growth

Spend segmentation by region

Regional spend dynamics

Regional influence on global spend

Regional spend opportunity for suppliers

PART 02: Market Summary

PART 03: Category Pricing Insights

Pricing outlook

Supplier cost structure

Outlook for input costs

Total cost of ownership analysis

Overview of pricing models

Comparison of pricing models

Supply chain margins

Cost drivers impacting pricing

Volume drivers impacting pricing

PART 04: Cost-Saving Opportunities

Supplier-side levers

Buyer-side levers

Quantifying cost-saving opportunities

Quantifying cost savings by negotiation strategies

PART 05: Best Practices

Innovation and success stories

Procurement excellence best practices

Procurement best practices

Sustainability practices

PART 06: Category Ecosystem

Market favorability index for suppliers

Competitiveness index for suppliers

Buyer power

Supplier power score

Threat of new entrants

Threat of substitutes

Buyer ecosystem

Supplier ecosystem

PART 07: Category Management Strategy

Category management objectives

Supplier and buyer KPIs

Outsourcing category management activities

Risk management

PART 08: Category Management Enablers

Procurement organization

Category enablers

PART 09: Suppliers Selection

RFx essentials

Supplier selection criteria

Service level agreement

Incumbent supplier evaluation metrics

PART 10: Suppliers Under Coverage

Overview

Supplier positioning

Profile: Pfizer

Profile: Boehringer Ingelheim

Profile: Lonza

Profile: Baxter

Profile: Catalent

Profile: Fresenius Kabi

PART 11: US Market Insights

Category spend in the US

Price outlook

Supplier cost structure in the US

Margins of suppliers in the US

Category cost drivers

Category volume drivers

Overview of best practices in the US

Procurement best practices in the US

US supply market overview

Supplier positioning for the US

Regional category risks

PART 12: Category Definition

Category hierarchy

Category scope

Category map

For more information about this report visit https://www.researchandmarkets.com/r/8creaj

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900